Umicore SA:企業の戦略・SWOT・財務情報

◆英語タイトル:Umicore SA - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C3648
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ベルギー
◆産業分野:エネルギー
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥24,150見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥48,300見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥72,450見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Umicore SA – Strategy, SWOT and Corporate Finance Report
Summary

Umicore SA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Umicore SA (Umicore or ‘the company’) also operating as Umicore NV, is a global materials technology and recycling company. It focuses in materials science, chemistry and metallurgy and is engaged in catalysis, energy and surface technologies and recycling activities. The company operates in Americas, Asia, Oceania, Europe and Africa. Umicore is headquartered in Brussels, Belgium.

Scope

- Detailed information on Umicore SA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Umicore SA in the form of a SWOT analysis
- An in-depth view of the business model of Umicore SA including a breakdown and examination of key business segments
- Intelligence on Umicore SA’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Umicore SA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Umicore SA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Umicore SA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Umicore SA’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Umicore SA: Company Overview 8
Umicore SA: Overview and Key Facts 8
Umicore SA: Overview 8
Umicore SA: Key Facts 8
Umicore SA: Key Employees 9
Umicore SA: Key Employee Biographies 10
Umicore SA: Major Products and Services 14
Umicore SA: Company History 15
Umicore SA: Management Statement 18
Umicore SA: Key Competitors 20
Umicore SA: Company Analysis 21
Umicore SA: Business Description 21
Umicore SA: SWOT Analysis 23
Umicore SA: SWOT Overview 23
Umicore SA: Strengths 23
Umicore SA: Weaknesses 24
Umicore SA: Opportunities 24
Umicore SA: Threats 25
Umicore SA: Corporate Financial Deals Activity 27
Umicore SA: Financial Deals Overview 27
Umicore SA: Targets and Partners 29
Umicore SA: Top Deals 2014 – 2018YTD* 30
Umicore SA: Advisors 31
Umicore SA: Top Legal Advisors 31
Umicore SA: Top Financial Advisors 31
Umicore SA: Mergers and Acquisitions 32
Umicore SA: Capital Raising 33
Umicore SA: Divestments 34
Umicore SA: Recent Developments 35
Umicore SA: News and Events Summary 35
Umicore SA: Business Expansion 37
Umicore SA: Corporate Governance 38
Umicore SA: Financial Performance 38
Umicore SA: Regulatory and Legal Events 39
Umicore SA: Strategy and Operations 39
Appendix 41
Contact Us 41
Methodology 41
About MarketLine 42

List of Tables
Table 1: Umicore SA: Key Facts
Table 2: Umicore SA: Key Employees
Table 3: Umicore SA: Key Competitors
Table 4: Umicore SA: Deal Activity by Deal Type - Volume (TTM*)
Table 5: Umicore SA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 6: Umicore SA: M&A Average Deal Size - Value (US$m)
Table 7: Umicore SA: Targets and Partners
Table 8: Umicore SA: Top Deals 2014 - 2018YTD*
Table 9: Umicore SA: Legal Advisor Ranking by Value (US$m)
Table 10: Umicore SA: Financial Advisor Ranking by Value (US$m)
Table 11: Umicore SA: M&A Volume and Value Trend (2014 - YTD*2018)
Table 12: Umicore SA: M&A Activity by Geography (2014 - YTD*2018)
Table 13: Umicore SA: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 14: Umicore SA: Capital Raising by Deal Type (2014 - YTD*2018)
Table 15: Umicore SA: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 16: Umicore SA: Divestments by Geography (2014 - YTD*2018)
Table 17: Umicore SA: News and Events Summary
Table 18: Umicore SA: Business Expansion
Table 19: Umicore SA: Corporate Governance
Table 20: Umicore SA: Financial Performance
Table 21: Umicore SA: Regulatory and Legal Events
Table 22: Umicore SA: Strategy and Operations

List of Figures
Figure 1: Umicore SA: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Umicore SA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Umicore SA: M&A Average Deal Size - Value (US$m)
Figure 4: Umicore SA: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Umicore SA: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Umicore SA: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 7: Umicore SA: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 8: Umicore SA: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 9: Umicore SA: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Umicore SA:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Biocad:製薬・医療:M&Aディール及び事業提携情報
    Summary Biocad is a biotechnology company that conducts research and development services. The company develops, manufactures and distributes generic pharmaceutical products. It develops products in urology, gynecology, dermatology, oncology, hematology, autoimmune diseases and infectious diseases t …
  • ConSynance Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary ConSynance Therapeutics Inc (ConSynance Therapeutics) is a drug discovery company that concentrates on the development of new therapeutic solutions for unmet medical needs. The company’s pipeline programs include CSTI-100, CSTI-200, and CSTI-300 among others. It develops pipeline programs fo …
  • AJ Lucas Group Ltd (AJL):企業の財務・戦略的SWOT分析
    AJ Lucas Group Ltd (AJL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Komunalna poistovna, a.s. Vienna Insurance Group:企業の戦略的SWOT分析
    Komunalna poistovna, a.s. Vienna Insurance Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competit …
  • Rev1 Ventures Inc.:企業のM&A・事業提携・投資動向
    Rev1 Ventures Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Rev1 Ventures Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Dynasil Corporation of America (DYSL):企業の財務・戦略的SWOT分析
    Summary Dynasil Corporation of America (Dynasil) is an electronic equipment company that develops and manufactures optics and photonics products. The company’s products include beam splitters, bandpass filters, coatings, crystal materials, imaging detectors, diffraction gratings, tunable light sourc …
  • CoreCivic, Inc. (CXW):企業の財務・戦略的SWOT分析
    CoreCivic, Inc. (CXW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • AIA Group Limited:企業の戦略・SWOT・財務情報
    AIA Group Limited - Strategy, SWOT and Corporate Finance Report Summary AIA Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Swift Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Swift Biosciences Inc (Swift Biosciences) is a biotechnology company that develops novel research reagents, protocols, and molecular diagnostic tools. The company’s products include 2S hyb DNA library kit, 2S plus DNA library kit, 2S PCR-free DNA library kit, methyl-seq DNA library kit, DNA …
  • adidas AG (ADS):企業の財務・戦略的SWOT分析
    adidas AG (ADS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Eversource Energy (ES)-エネルギー分野:企業M&A・提携分析
    Summary Eversource Energy (Eversource) is a utility holding company which operates energy delivery business through its subsidiaries. It transmits and distributes electricity and natural gas. The company sources electricity from its facilities, long-term power supply agreements, and competitive ener …
  • Lexicon Pharmaceuticals Inc (LXRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Lexicon Pharmaceuticals Inc (Lexicon) is a biopharmaceutical company, which focuses on the discovery, development and commercialization of innovative treatments for human diseases. The company has advanced multiple drug candidates into clinical development and has clinical-stage drug program …
  • MedinCell SA:製薬・医療:M&Aディール及び事業提携情報
    Summary MedinCell SA (MedinCell) is a developer of therapeutic solutions for the healthcare market. The company develops and commercializes BEPO, a technology based on custom proprietary copolymers and a biocompatible solvent for long acting injectables. Its BEPO provides a controlled release of the …
  • Asian Development Bank:企業のM&A・事業提携・投資動向
    Asian Development Bank - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Asian Development Bank Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Fraport Slovenija, d.o.o.:企業の戦略・SWOT・財務情報
    Fraport Slovenija, d.o.o. - Strategy, SWOT and Corporate Finance Report Summary Fraport Slovenija, d.o.o. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • University of Texas MD Anderson Cancer Center:企業の戦略的SWOT分析
    University of Texas MD Anderson Cancer Center - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Utair Aviation
    Utair Aviation - Strategy, SWOT and Corporate Finance Report Summary Utair Aviation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Covalon Technologies Ltd (COV):企業の財務・戦略的SWOT分析
    Summary Covalon Technologies Ltd (Covalon) is a researcher, developer and commercializer of medical products and healthcare technologies. The company offers advanced wound care, infection prevention and perioperative care products. Its wound care products include collagen matrix dressing, collagen m …
  • Kirin Holdings Co Ltd:企業の戦略・SWOT・財務情報
    Kirin Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Kirin Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Chicago Bridge & Iron Company NV (CBI):電力:M&Aディール及び事業提携情報
    Summary Chicago Bridge & Iron Company NV (CB&I) is a provider of technology and infrastructure solutions. Its services include conceptual design, technology, engineering, procurement, modularization, construction, fabrication, commissioning, maintenance, program management and environmental services …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆